Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $13.8 million.

  • Healthcare Triangle's Liabilities and Shareholders Equity rose 19034.83% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year increase of 7192.97%. This contributed to the annual value of $2.0 million for FY2024, which is 7140.57% down from last year.
  • Healthcare Triangle's Liabilities and Shareholders Equity amounted to $13.8 million in Q3 2025, which was up 19034.83% from $14.6 million recorded in Q2 2025.
  • Over the past 5 years, Healthcare Triangle's Liabilities and Shareholders Equity peaked at $24.9 million during Q3 2022, and registered a low of $2.0 million during Q4 2024.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $13.8 million (2025), whereas its average is $13.8 million.
  • In the last 5 years, Healthcare Triangle's Liabilities and Shareholders Equity plummeted by 7140.57% in 2024 and then surged by 19034.83% in 2025.
  • Over the past 5 years, Healthcare Triangle's Liabilities and Shareholders Equity (Quarter) stood at $24.6 million in 2021, then crashed by 46.12% to $13.3 million in 2022, then plummeted by 48.29% to $6.9 million in 2023, then tumbled by 71.41% to $2.0 million in 2024, then surged by 605.66% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q3 2025, $14.6 million for Q2 2025, and $11.8 million during Q1 2025.